These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 20586697)

  • 1. Management of antipsychotic-related weight gain.
    Maayan L; Correll CU
    Expert Rev Neurother; 2010 Jul; 10(7):1175-200. PubMed ID: 20586697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.
    Maayan L; Vakhrusheva J; Correll CU
    Neuropsychopharmacology; 2010 Jun; 35(7):1520-30. PubMed ID: 20336059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
    Maayan L; Correll CU
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological management of atypical antipsychotic-induced weight gain.
    Baptista T; ElFakih Y; Uzcátegui E; Sandia I; Tálamo E; Araujo de Baptista E; Beaulieu S
    CNS Drugs; 2008; 22(6):477-95. PubMed ID: 18484791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.
    Das C; Mendez G; Jagasia S; Labbate LA
    Ann Clin Psychiatry; 2012 Aug; 24(3):225-39. PubMed ID: 22860242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of weight gain associated with antipsychotics.
    Birt J
    Ann Clin Psychiatry; 2003 Mar; 15(1):49-58. PubMed ID: 12839432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
    Himmerich H; Schuld A; Pollmächer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia.
    Marteene W; Winckel K; Hollingworth S; Kisely S; Gallagher E; Hahn M; Ebdrup BH; Firth J; Siskind D
    Expert Opin Drug Saf; 2019 Dec; 18(12):1149-1160. PubMed ID: 31564170
    [No Abstract]   [Full Text] [Related]  

  • 12. Options for pharmacological management of obesity in patients treated with atypical antipsychotics.
    Werneke U; Taylor D; Sanders TA
    Int Clin Psychopharmacol; 2002 Jul; 17(4):145-60. PubMed ID: 12131598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials.
    Caemmerer J; Correll CU; Maayan L
    Schizophr Res; 2012 Sep; 140(1-3):159-68. PubMed ID: 22763424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-pharmacological interventions for weight gain in patients with schizophrenia taking antipsychotics].
    Attux C; Martini LC; Reis AF; Bressan RA
    Arq Bras Endocrinol Metabol; 2009 Jun; 53(4):391-8. PubMed ID: 19649375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes in children and adolescents on atypical antipsychotics.
    Pramyothin P; Khaodhiar L
    Curr Diab Rep; 2015 Aug; 15(8):53. PubMed ID: 26084582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.